Reata Pharmaceuticals announced the appointment of Rajiv Patni, M.D., as Executive Vice President, and Chief Research & Development Officer. Dr. Patni will report to Warren Huff, CEO, and will be responsible for overseeing the company’s research and development functions. Prior to joining Reata, Dr. Patni was Chief Medical Officer at Global Blood Therapeutics from 2020 to 2023.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RETA: